- Corporate Officers - H
- Hutt Peter Barton
Insider Trading History of Hutt Peter Barton
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hutt Peter Barton since 2010.
This trader's CIK number is 1171527.
At the time of last reporting, Hutt Peter Barton was the Director of Concert Pharmaceuticals, Inc.. (stock ticker symbol CNCE).
Also see all insider trading activities at Concert Pharmaceuticals, Inc..
Note that in the past
HUTT PETER BARTON also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Moderna, Inc. (MRNA) by Hutt Peter Barton
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | MRNA | 0 | $0 | 300,000 | $5,799,000 | 300,000 | $12,000 |
Yearly summary of insider trading at Momenta Pharmaceuticals Inc (MNTA) by Hutt Peter Barton
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | MNTA | 0 | $0 | 3,640 | $41,568 | 0 | $0 |
| 2010 | MNTA | 0 | $0 | 126,498 | $1,835,245 | 64,000 | $14,784 |
Yearly summary of insider trading at Bind Therapeutics, Inc (BIND) by Hutt Peter Barton
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | BIND | 0 | $0 | 0 | $0 | 15,000 | $6,600 |
Yearly summary of insider trading at Concert Pharmaceuticals, Inc. (CNCE) by Hutt Peter Barton
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | CNCE | 0 | $0 | 3,539 | $21,552 | 3,539 | $10,192 |
| 2020 | CNCE | 0 | $0 | 0 | $0 | 3,539 | $13,412 |
| 2019 | CNCE | 0 | $0 | 3,539 | $36,487 | 3,539 | $15,606 |
| 2016 | CNCE | 0 | $0 | 22,123 | $217,026 | 22,123 | $24,998 |
Yearly summary of insider trading at Q Therapeutics, Inc. ([NONE]) by Hutt Peter Barton
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | [NONE] | 0 | $0 | 0 | $0 | 32,451 | $4,867 |
Insider trading activities at 5 companies by Hutt Peter Barton:
1. Moderna, Inc. (MRNA)
2. Momenta Pharmaceuticals Inc (MNTA)
3. Bind Therapeutics, Inc (BIND)
4. Concert Pharmaceuticals, Inc. (CNCE)
5. Q Therapeutics, Inc. ([NONE])
Table 1. Insider trading of Moderna, Inc. (MRNA) by Hutt Peter Barton
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-11-20 | MRNA | Option Ex | 200,000 | .04 | 8,000 |
| 2019-11-20 | MRNA | Sale | 200,000 | 20.18 | 4,036,000 |
| 2019-09-17 | MRNA | Sale | 100,000 | 17.63 | 1,763,000 |
| 2019-09-17 | MRNA | Option Ex | 100,000 | .04 | 4,000 |
Table 2. Insider trading of Momenta Pharmaceuticals Inc (MNTA) by Hutt Peter Barton
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-09-12 | MNTA | Sale | 3,640 | 11.42 | 41,568 |
| 2010-12-10 | MNTA | Sale | 62,498 | 14.67 | 916,845 |
| 2010-12-14 | MNTA | Option Ex | 64,000 | .23 | 14,784 |
| 2010-12-14 | MNTA | Sale | 64,000 | 14.35 | 918,400 |
Table 3. Insider trading of Bind Therapeutics, Inc (BIND) by Hutt Peter Barton
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-08-29 | BIND | Option Ex | 15,000 | .44 | 6,600 |
Table 4. Insider trading of Concert Pharmaceuticals, Inc. (CNCE) by Hutt Peter Barton
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-10-14 | CNCE | Option Ex | 3,539 | 2.88 | 10,192 |
| 2022-10-14 | CNCE | Sale | 3,539 | 6.09 | 21,552 |
| 2020-08-31 | CNCE | Option Ex | 3,539 | 3.79 | 13,412 |
| 2019-08-08 | CNCE | Sale | 3,539 | 10.31 | 36,487 |
| 2019-08-08 | CNCE | Option Ex | 3,539 | 4.41 | 15,606 |
| 2016-11-14 | CNCE | Option Ex | 22,123 | 1.13 | 24,998 |
| 2016-11-14 | CNCE | Sale | 22,123 | 9.81 | 217,026 |
Table 5. Insider trading of Q Therapeutics, Inc. ([NONE]) by Hutt Peter Barton
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-07-14 | [NONE] | Option Ex | 32,451 | .15 | 4,867 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hutt Peter Barton
(Director of Concert Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.